Inventor
Steven McKerrall
Inventor
South San Francisco, CA, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes24%
C07BGeneral methods of organic chemistry5%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
11,028,075Therapeutic compounds and methods of use thereof202110,947,251Therapeutic compounds and methods of use thereof202110,899,732Substituted benzamides useful as sodium channel blockers202110,793,5504-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors202010,787,446Therapeutic compounds and methods of use thereof202010,766,858Substituted benzamides and methods of use thereof202010,457,654Therapeutic compounds and methods of use thereof2019Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2019–2021Patents assigned to GENENTECH INC (7)· patent assignee history
2019–2021Patents assigned to XENON PHARMACEUTICALS INC (4)· patent assignee history
2019–2021Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 7 | 2019–2021 |
| XENON PHARMACEUTICALS INC | 4 | 2019–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| South San Francisco, California, US | 7 | 2019–2021 |